000 | 01184 a2200313 4500 | ||
---|---|---|---|
005 | 20250516050853.0 | ||
264 | 0 | _c20111223 | |
008 | 201112s 0 0 eng d | ||
022 | _a1365-2036 | ||
024 | 7 |
_a10.1111/j.1365-2036.2011.04778.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDeshpande, A R | |
245 | 0 | 0 |
_aPrediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study. _h[electronic resource] |
260 |
_bAlimentary pharmacology & therapeutics _cSep 2011 |
||
300 |
_a586 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 |
_aCrohn Disease _xdiagnosis |
650 | 0 | 4 |
_aFeces _xchemistry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocyte L1 Antigen Complex _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xtherapeutic use |
700 | 1 | _aStrobel, S | |
773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 34 _gno. 5 _gp. 586 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2011.04778.x _zAvailable from publisher's website |
999 |
_c21052299 _d21052299 |